Jan 20, 2024, 17:23
Shushan Hovsepyan: Have you checked the MASCC/ESMO update on CT-induced nausea/vomiting?
Shushan Hovsepyan, Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center, shared on X/Twitter:
”Have you checked the MASCC/ESMO update on CT-induced nausea/vomiting?
- High-dose CT and stem-cell transplant = 5-HT3 antagonist+dexa+aprepitant,
- Multi-day Cisplatin= 5-HT3antagonist+dexa +aprepitant +olanzapine,
- Breakthrough N/V=single dose olanzapine 3day.”
Read further.
Source: Shushan Hovsepyan/X
Aug 16, 2024, 20:23